Annual CFF
$3.42 M
+$3.05 M+833.06%
October 1, 2024
Summary
- As of February 23, 2025, ANIX annual cash flow from financing activities is $3.42 million, with the most recent change of +$3.05 million (+833.06%) on October 1, 2024.
- During the last 3 years, ANIX annual CFF has fallen by -$28.15 million (-89.18%).
- ANIX annual CFF is now -89.18% below its all-time high of $31.57 million, reached on October 31, 2021.
Performance
ANIX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$106.00 K
-$43.00 K-28.86%
October 1, 2024
Summary
- As of February 23, 2025, ANIX quarterly cash flow from financing activities is $106.00 thousand, with the most recent change of -$43.00 thousand (-28.86%) on October 1, 2024.
- Over the past year, ANIX quarterly CFF has stayed the same.
- ANIX quarterly CFF is now -99.58% below its all-time high of $25.36 million, reached on April 30, 2021.
Performance
ANIX Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$3.42 M
-$173.00 K-4.82%
October 1, 2024
Summary
- As of February 23, 2025, ANIX TTM cash flow from financing activities is $3.42 million, with the most recent change of -$173.00 thousand (-4.82%) on October 1, 2024.
- Over the past year, ANIX TTM CFF has stayed the same.
- ANIX TTM CFF is now -90.94% below its all-time high of $37.68 million, reached on April 30, 2021.
Performance
ANIX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
ANIX Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +833.1% | 0.0% | 0.0% |
| 3 y3 years | -89.2% | 0.0% | 0.0% |
| 5 y5 years | -40.1% | 0.0% | 0.0% |
ANIX Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -89.2% | +833.1% | -95.3% | +127.6% | -86.6% | +1249.8% |
| 5 y | 5-year | -89.2% | +833.1% | -99.6% | +127.6% | -90.9% | +1249.8% |
| alltime | all time | -89.2% | +952.5% | -99.6% | +121.4% | -90.9% | +787.1% |
Anixa Biosciences Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Oct 2024 | $3.42 M(+833.1%) | $106.00 K(-28.9%) | $3.42 M(-4.8%) |
| Jul 2024 | - | $149.00 K(-83.4%) | $3.59 M(+4.2%) |
| Apr 2024 | - | $897.00 K(-60.4%) | $3.44 M(+31.1%) |
| Jan 2024 | - | $2.26 M(+711.1%) | $2.63 M(+617.5%) |
| Oct 2023 | $366.00 K(-19.0%) | $279.00 K(+9200.0%) | $366.00 K(-223.2%) |
| Jul 2023 | - | $3000.00(-96.3%) | -$297.00 K(-156.1%) |
| Apr 2023 | - | $81.00 K(+2600.0%) | $529.00 K(+16.3%) |
| Jan 2023 | - | $3000.00(-100.8%) | $455.00 K(+0.7%) |
| Oct 2022 | $452.00 K(-98.6%) | -$384.00 K(-146.3%) | $452.00 K(-53.9%) |
| Jul 2022 | - | $829.00 K(>+9900.0%) | $980.00 K(+549.0%) |
| Apr 2022 | - | $7000.00(>+9900.0%) | $151.00 K(-99.4%) |
| Jan 2022 | - | $0.00(-100.0%) | $25.50 M(-19.2%) |
| Oct 2021 | $31.57 M(+235.6%) | $144.00 K(>+9900.0%) | $31.57 M(-3.8%) |
| Jul 2021 | - | $0.00(-100.0%) | $32.83 M(-12.9%) |
| Apr 2021 | - | $25.36 M(+318.4%) | $37.68 M(+175.3%) |
| Jan 2021 | - | $6.06 M(+332.0%) | $13.69 M(+45.5%) |
| Oct 2020 | $9.41 M(+65.0%) | $1.40 M(-71.1%) | $9.41 M(+8.3%) |
| Jul 2020 | - | $4.85 M(+253.4%) | $8.69 M(+97.4%) |
| Apr 2020 | - | $1.37 M(-22.9%) | $4.40 M(-17.1%) |
| Jan 2020 | - | $1.78 M(+161.1%) | $5.31 M(-6.9%) |
| Oct 2019 | $5.70 M(+125.6%) | $681.80 K(+20.8%) | $5.70 M(-1.0%) |
| Jul 2019 | - | $564.60 K(-75.2%) | $5.76 M(-8.6%) |
| Apr 2019 | - | $2.28 M(+4.8%) | $6.31 M(+34.1%) |
| Jan 2019 | - | $2.18 M(+193.2%) | $4.70 M(+86.1%) |
| Oct 2018 | $2.53 M(-65.8%) | $742.30 K(-33.0%) | $2.53 M(-22.2%) |
| Jul 2018 | - | $1.11 M(+63.7%) | $3.25 M(-25.4%) |
| Apr 2018 | - | $677.40 K(>+9900.0%) | $4.35 M(-44.8%) |
| Jan 2018 | - | $0.00(-100.0%) | $7.88 M(+6.7%) |
| Oct 2017 | $7.38 M(<-9900.0%) | $1.46 M(-33.9%) | $7.38 M(+25.2%) |
| Jul 2017 | - | $2.21 M(-47.4%) | $5.89 M(+59.8%) |
| Apr 2017 | - | $4.20 M(-950.4%) | $3.69 M(-842.1%) |
| Jan 2017 | - | -$494.30 K(+1793.9%) | -$497.00 K(>+9900.0%) |
| Oct 2016 | -$2700.00(-99.3%) | -$26.10 K(-601.9%) | -$2700.00(-108.0%) |
| Jul 2016 | - | $5200.00(-71.4%) | $33.70 K(-118.5%) |
| Apr 2016 | - | $18.20 K(>+9900.0%) | -$182.40 K(-54.5%) |
| Jan 2016 | - | $0.00(-100.0%) | -$400.60 K(0.0%) |
| Oct 2015 | -$400.60 K(-105.5%) | $10.30 K(-104.9%) | -$400.60 K(+3.7%) |
| Jul 2015 | - | -$210.90 K(+5.5%) | -$386.30 K(-110.4%) |
| Apr 2015 | - | -$200.00 K(-913.0%) | $3.70 M(-49.7%) |
| Oct 2014 | $7.35 M(+126.4%) | $24.60 K(-99.4%) | $7.35 M(-5.6%) |
| Jul 2014 | - | $3.87 M(-7957.4%) | $7.78 M(+74.5%) |
| Apr 2014 | - | -$49.30 K(-101.4%) | $4.46 M(-10.5%) |
| Jan 2014 | - | $3.50 M(+660.0%) | $4.98 M(+53.5%) |
| Oct 2013 | $3.25 M(+238.7%) | $460.50 K(-16.1%) | $3.25 M(-8.2%) |
| Jul 2013 | - | $549.00 K(+16.5%) | $3.54 M(+18.4%) |
| Apr 2013 | - | $471.40 K(-73.3%) | $2.99 M(+15.9%) |
| Jan 2013 | - | $1.76 M(+135.3%) | $2.58 M(+168.8%) |
| Oct 2012 | $958.50 K(-62.2%) | $750.00 K(>+9900.0%) | $958.40 K(+143.5%) |
| Jul 2012 | - | $0.00(-100.0%) | $393.60 K(-57.0%) |
| Apr 2012 | - | $61.20 K(-58.4%) | $915.00 K(-58.5%) |
| Jan 2012 | - | $147.20 K(-20.5%) | $2.20 M(-13.0%) |
| Oct 2011 | $2.53 M(+102.9%) | $185.20 K(-64.5%) | $2.53 M(-0.6%) |
| Jul 2011 | - | $521.40 K(-61.4%) | $2.55 M(+14.7%) |
| Apr 2011 | - | $1.35 M(+182.5%) | $2.22 M(+86.0%) |
| Jan 2011 | - | $477.80 K(+139.5%) | $1.19 M(-4.3%) |
| Oct 2010 | $1.25 M(-36.7%) | $199.50 K(+2.0%) | $1.25 M(-29.6%) |
| Jul 2010 | - | $195.50 K(-39.3%) | $1.77 M(-14.3%) |
| Apr 2010 | - | $322.00 K(-39.5%) | $2.07 M(-0.4%) |
| Jan 2010 | - | $532.00 K(-26.5%) | $2.08 M(+5.4%) |
| Oct 2009 | $1.97 M(-89.5%) | $724.10 K(+47.3%) | $1.97 M(+19.3%) |
| Jul 2009 | - | $491.50 K(+48.6%) | $1.65 M(+5.3%) |
| Apr 2009 | - | $330.70 K(-22.4%) | $1.57 M(-18.7%) |
| Jan 2009 | - | $425.90 K(+5.2%) | $1.93 M(-89.7%) |
| Oct 2008 | $18.71 M(+766.4%) | $405.00 K(-0.9%) | $18.71 M(-0.8%) |
| Jul 2008 | - | $408.70 K(-40.9%) | $18.86 M(+0.0%) |
| Apr 2008 | - | $692.00 K(-96.0%) | $18.86 M(+1.2%) |
| Jan 2008 | - | $17.21 M(+3015.4%) | $18.63 M(+762.5%) |
| Oct 2007 | $2.16 M | $552.30 K(+36.2%) | $2.16 M(-4.8%) |
| Jul 2007 | - | $405.40 K(-12.7%) | $2.27 M(-2.5%) |
| Apr 2007 | - | $464.50 K(-37.0%) | $2.33 M(-3.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jan 2007 | - | $737.60 K(+11.4%) | $2.41 M(+1.1%) |
| Oct 2006 | $2.38 M(+46.2%) | $662.00 K(+42.6%) | $2.38 M(+15.0%) |
| Jul 2006 | - | $464.30 K(-14.6%) | $2.07 M(+4.3%) |
| Apr 2006 | - | $543.50 K(-23.5%) | $1.99 M(+6.6%) |
| Jan 2006 | - | $710.70 K(+101.7%) | $1.86 M(+14.4%) |
| Oct 2005 | $1.63 M(+35.7%) | $352.40 K(-7.1%) | $1.63 M(-0.7%) |
| Jul 2005 | - | $379.20 K(-9.8%) | $1.64 M(+14.0%) |
| Apr 2005 | - | $420.50 K(-11.8%) | $1.44 M(-8.1%) |
| Jan 2005 | - | $476.50 K(+31.0%) | $1.57 M(+30.5%) |
| Oct 2004 | $1.20 M(+6.4%) | $363.70 K(+104.7%) | $1.20 M(+4.7%) |
| Jul 2004 | - | $177.70 K(-67.6%) | $1.15 M(-32.5%) |
| Apr 2004 | - | $547.70 K(+394.3%) | $1.70 M(+40.9%) |
| Jan 2004 | - | $110.80 K(-64.3%) | $1.20 M(+6.8%) |
| Oct 2003 | $1.13 M(>+9900.0%) | $310.00 K(-57.4%) | $1.13 M(+37.9%) |
| Jul 2003 | - | $728.50 K(+1212.6%) | $818.20 K(+737.5%) |
| Apr 2003 | - | $55.50 K(+62.3%) | $97.70 K(+131.5%) |
| Jan 2003 | - | $34.20 K(>+9900.0%) | $42.20 K(+427.5%) |
| Oct 2002 | $8000.00(-99.0%) | $0.00(-100.0%) | $8000.00(0.0%) |
| Jul 2002 | - | $8000.00(>+9900.0%) | $8000.00(-93.2%) |
| Apr 2002 | - | $0.00(0.0%) | $118.00 K(-63.2%) |
| Jan 2002 | - | $0.00(0.0%) | $320.40 K(-60.9%) |
| Oct 2001 | $819.80 K(-79.6%) | $0.00(-100.0%) | $819.80 K(0.0%) |
| Jul 2001 | - | $118.00 K(-41.7%) | $819.80 K(-9.1%) |
| Apr 2001 | - | $202.40 K(-59.5%) | $901.80 K(-74.4%) |
| Jan 2001 | - | $499.40 K(>+9900.0%) | $3.53 M(-12.4%) |
| Oct 2000 | $4.03 M(+43.8%) | $0.00(-100.0%) | $4.03 M(-18.3%) |
| Jul 2000 | - | $200.00 K(-92.9%) | $4.93 M(-3.9%) |
| Apr 2000 | - | $2.83 M(+182.6%) | $5.13 M(+70.9%) |
| Jan 2000 | - | $1.00 M(+11.1%) | $3.00 M(+7.1%) |
| Oct 1999 | $2.80 M(>+9900.0%) | $900.00 K(+125.0%) | $2.80 M(+47.4%) |
| Jul 1999 | - | $400.00 K(-42.9%) | $1.90 M(+26.7%) |
| Apr 1999 | - | $700.00 K(-12.5%) | $1.50 M(+87.5%) |
| Jan 1999 | - | $800.00 K(>+9900.0%) | $800.00 K(>+9900.0%) |
| Oct 1998 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Jul 1998 | - | $0.00(0.0%) | $300.00 K(-25.0%) |
| Apr 1998 | - | $0.00(0.0%) | $400.00 K(-75.0%) |
| Jan 1998 | - | $0.00(-100.0%) | $1.60 M(-11.1%) |
| Oct 1997 | $1.80 M(-90.4%) | $300.00 K(+200.0%) | $1.80 M(-50.0%) |
| Jul 1997 | - | $100.00 K(-91.7%) | $3.60 M(-71.9%) |
| Apr 1997 | - | $1.20 M(+500.0%) | $12.80 M(-22.0%) |
| Jan 1997 | - | $200.00 K(-90.5%) | $16.40 M(-12.8%) |
| Oct 1996 | $18.80 M(+213.3%) | $2.10 M(-77.4%) | $18.80 M(+5.0%) |
| Jul 1996 | - | $9.30 M(+93.8%) | $17.90 M(+54.3%) |
| Apr 1996 | - | $4.80 M(+84.6%) | $11.60 M(+34.9%) |
| Jan 1996 | - | $2.60 M(+116.7%) | $8.60 M(+43.3%) |
| Oct 1995 | $6.00 M(+275.0%) | $1.20 M(-60.0%) | $6.00 M(+22.4%) |
| Jul 1995 | - | $3.00 M(+66.7%) | $4.90 M(+69.0%) |
| Apr 1995 | - | $1.80 M(>+9900.0%) | $2.90 M(+81.3%) |
| Jan 1995 | - | $0.00(-100.0%) | $1.60 M(0.0%) |
| Oct 1994 | $1.60 M(-76.8%) | $100.00 K(-90.0%) | $1.60 M(-44.8%) |
| Jul 1994 | - | $1.00 M(+100.0%) | $2.90 M(-35.6%) |
| Apr 1994 | - | $500.00 K(>+9900.0%) | $4.50 M(-10.0%) |
| Jan 1994 | - | $0.00(-100.0%) | $5.00 M(-27.5%) |
| Oct 1993 | $6.90 M(+305.9%) | $1.40 M(-46.2%) | $6.90 M(+15.0%) |
| Jul 1993 | - | $2.60 M(+160.0%) | $6.00 M(+66.7%) |
| Apr 1993 | - | $1.00 M(-47.4%) | $3.60 M(+16.1%) |
| Jan 1993 | - | $1.90 M(+280.0%) | $3.10 M(+82.4%) |
| Oct 1992 | $1.70 M(+21.4%) | $500.00 K(+150.0%) | $1.70 M(0.0%) |
| Jul 1992 | - | $200.00 K(-60.0%) | $1.70 M(-5.6%) |
| Apr 1992 | - | $500.00 K(0.0%) | $1.80 M(+12.5%) |
| Jan 1992 | - | $500.00 K(0.0%) | $1.60 M(+14.3%) |
| Oct 1991 | $1.40 M(+27.3%) | $500.00 K(+66.7%) | $1.40 M(+16.7%) |
| Jul 1991 | - | $300.00 K(0.0%) | $1.20 M(+9.1%) |
| Apr 1991 | - | $300.00 K(0.0%) | $1.10 M(0.0%) |
| Jan 1991 | - | $300.00 K(0.0%) | $1.10 M(0.0%) |
| Oct 1990 | $1.10 M(-66.7%) | $300.00 K(+50.0%) | $1.10 M(+37.5%) |
| Jul 1990 | - | $200.00 K(-33.3%) | $800.00 K(+33.3%) |
| Apr 1990 | - | $300.00 K(0.0%) | $600.00 K(+100.0%) |
| Jan 1990 | - | $300.00 K | $300.00 K |
| Oct 1989 | $3.30 M | - | - |
FAQ
- What is Anixa Biosciences annual cash flow from financing activities?
- What is the all time high annual CFF for Anixa Biosciences?
- What is Anixa Biosciences annual CFF year-on-year change?
- What is Anixa Biosciences quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Anixa Biosciences?
- What is Anixa Biosciences quarterly CFF year-on-year change?
- What is Anixa Biosciences TTM cash flow from financing activities?
- What is the all time high TTM CFF for Anixa Biosciences?
- What is Anixa Biosciences TTM CFF year-on-year change?
What is Anixa Biosciences annual cash flow from financing activities?
The current annual CFF of ANIX is $3.42 M
What is the all time high annual CFF for Anixa Biosciences?
Anixa Biosciences all-time high annual cash flow from financing activities is $31.57 M
What is Anixa Biosciences annual CFF year-on-year change?
Over the past year, ANIX annual cash flow from financing activities has changed by +$3.05 M (+833.06%)
What is Anixa Biosciences quarterly cash flow from financing activities?
The current quarterly CFF of ANIX is $106.00 K
What is the all time high quarterly CFF for Anixa Biosciences?
Anixa Biosciences all-time high quarterly cash flow from financing activities is $25.36 M
What is Anixa Biosciences quarterly CFF year-on-year change?
Over the past year, ANIX quarterly cash flow from financing activities has changed by $0.00 (0.00%)
What is Anixa Biosciences TTM cash flow from financing activities?
The current TTM CFF of ANIX is $3.42 M
What is the all time high TTM CFF for Anixa Biosciences?
Anixa Biosciences all-time high TTM cash flow from financing activities is $37.68 M
What is Anixa Biosciences TTM CFF year-on-year change?
Over the past year, ANIX TTM cash flow from financing activities has changed by $0.00 (0.00%)